Company Overview of Aarden Pharmaceuticals, Inc.
Aarden Pharmaceuticals, Inc. operates as a small molecule drug discovery and development company. It develops drugs targeting the phosphatase family of proteins with emphasis on protein tyrosine phosphatases that catalyze the removal of phosphate groups from tyrosine residues of proteins and play key roles along with the tyrosine kinases in various signal transduction pathways. The company’s drug programs focus on infectious diseases, cancer, metabolic, and autoimmune therapeutic areas. Aarden Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Indianapolis, Indiana.
351 West 10th Street
Indianapolis, IN 46202
Founded in 2008
Key Executives for Aarden Pharmaceuticals, Inc.
Similar Private Companies By Industry
|COLD-fX Pharmaceuticals (USA), Inc.||United States|
|Novartis Capital Corporation||United States|
|Silkit Pharma Corporation||United States|
|Spring Bank Pharmaceuticals, Inc.||United States|
|ISW Group, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Aarden Pharmaceuticals, Inc., please visit www.aardenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.